Business Strategy

airPharma's objective is to become a leading specialty pharmaceutical company by leveraging the significant experience of the Company's management team in respiratory diseases, drug development and sales and marketing. The key elements of the Company's strategy are to:

• capitalize on the significant void of companies and products in the specialty respiratory therapeutic market;
• leverage expertise in respiratory disease to identify unique therapeutic candidates;
• target low risk product development programs by developing products candidates with proven safety profiles;
• design shortened development and regulatory approval pathways by focusing on development candidates in niche indications;
• build and execute specialty sales and marketing programs leveraging management's significant experience in specialty sales and marketing; and
• pursue multiple indications for individual compounds.